These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 30158057)
1. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057 [TBL] [Abstract][Full Text] [Related]
2. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. Ambrosy AP; Bhatt AS; Stebbins AL; Wruck LM; Fudim M; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Mentz RJ Am Heart J; 2018 May; 199():97-104. PubMed ID: 29754673 [TBL] [Abstract][Full Text] [Related]
4. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure. Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis. Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731 [TBL] [Abstract][Full Text] [Related]
6. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029 [TBL] [Abstract][Full Text] [Related]
7. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947 [TBL] [Abstract][Full Text] [Related]
8. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631 [TBL] [Abstract][Full Text] [Related]
9. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181 [TBL] [Abstract][Full Text] [Related]
10. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996 [TBL] [Abstract][Full Text] [Related]
11. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry. Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH; Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110 [TBL] [Abstract][Full Text] [Related]
12. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139 [TBL] [Abstract][Full Text] [Related]
13. Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials. Shah SJ; Sharma K; Borlaug BA; Butler J; Davies M; Kitzman DW; Petrie MC; Verma S; Patel S; Chinnakondepalli KM; Einfeldt MN; Jensen TJ; Rasmussen S; Asleh R; Ben-Gal T; Kosiborod MN Eur Heart J; 2024 Sep; 45(35):3254-3269. PubMed ID: 38739118 [TBL] [Abstract][Full Text] [Related]
14. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H; Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070 [TBL] [Abstract][Full Text] [Related]
15. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131 [TBL] [Abstract][Full Text] [Related]
16. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ; Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600 [TBL] [Abstract][Full Text] [Related]
17. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions. Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770 [TBL] [Abstract][Full Text] [Related]
18. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex. Piña IL; Bittner V; Clare RM; Swank A; Kao A; Safford R; Nigam A; Barnard D; Walsh MN; Ellis SJ; Keteyian SJ; JACC Heart Fail; 2014 Apr; 2(2):180-6. PubMed ID: 24720927 [TBL] [Abstract][Full Text] [Related]
19. Addition of Supervised Exercise Training to a Post-Hospital Disease Management Program for Patients Recently Hospitalized With Acute Heart Failure: The EJECTION-HF Randomized Phase 4 Trial. Mudge AM; Denaro CP; Scott AC; Meyers D; Adsett JA; Mullins RW; Suna JM; Atherton JJ; Marwick TH; Scuffham P; O'Rourke P JACC Heart Fail; 2018 Feb; 6(2):143-152. PubMed ID: 29413370 [TBL] [Abstract][Full Text] [Related]
20. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction. Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]